Virios Therapeutics, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.05) Per Share (NASDAQ:VIRI)
Virios Therapeutics, Inc. (NASDAQ:VIRI – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Virios Therapeutics in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst S. Lee forecasts that the company will post earnings of ($0.05) per share for the quarter. […]
More Stories
Top Cryptocurrency Stocks To Watch Now – April 8th
Robinhood Markets, Bit Origin, and Bitdeer Technologies Group are the three Cryptocurrency stocks to watch today, according to MarketBeat’s stock...
Best Gold Stocks Worth Watching – April 8th
Robinhood Markets, Coca-Cola, and Freeport-McMoRan are the three Gold stocks to watch today, according to MarketBeat’s stock screener tool. Gold...
Arrowstreet Capital Limited Partnership Acquires 9,713 Shares of The Middleby Co. (NASDAQ:MIDD)
Arrowstreet Capital Limited Partnership increased its stake in shares of The Middleby Co. (NASDAQ:MIDD – Free Report) by 157.9% during...
Palomar (NASDAQ:PLMR) Upgraded at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Palomar (NASDAQ:PLMR – Free Report) from a neutral rating to an overweight rating...
NVIDIA Co. (NASDAQ:NVDA) Shares Sold by Schrum Private Wealth Management LLC
Schrum Private Wealth Management LLC cut its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 56.3% in the fourth...
8,268 Shares in NVIDIA Co. (NASDAQ:NVDA) Bought by Aigen Investment Management LP
Aigen Investment Management LP acquired a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the 4th...